论文部分内容阅读
目的探讨步长稳心颗粒联合常规用药治疗不稳定性心绞痛的临床观察。方法对住院确诊为不稳定性心绞痛的患者采用随机方法,分为治疗组和对照组,治疗组使用稳心颗粒联合常规用药治疗。步长稳心颗粒9g/次,3次/d,温水冲服,疗程为4周。对照组常规给予ADP受体拮抗剂,β受体阻滞剂,硝酸酯类药物,钙拮抗剂等药物治疗。结果治疗组临床治疗效果明显,患者好转率明显优于对照组,且治疗效果好于对照组(P<0.05),两组不良反应比较差异无统计学差义(P>0.05)。结论步长稳心颗粒联合常规用药治疗不稳定性心绞痛治疗时间短,临床治疗效果明显,不良反应小,安全可靠。
Objective To investigate the clinical observation of step-stabilizing granule combined with conventional medicine in the treatment of unstable angina pectoris. Methods Randomized treatment of patients with unstable angina pectoris admitted to hospital were divided into treatment group and control group. The treatment group was treated with Wenxin granule combined with conventional medication. Step steady heart particles 9g / time, 3 times / d, warm water blunt, treatment for 4 weeks. Control group routinely given ADP receptor antagonist, β-blockers, nitrates, calcium antagonists and other drug treatment. Results The therapeutic effect of the treatment group was obvious. The improvement rate of the patients was obviously better than that of the control group, and the treatment effect was better than that of the control group (P <0.05). There was no significant difference between the two groups in adverse reactions (P> 0.05). Conclusion The step-stabilizing granule combined with conventional treatment of unstable angina pectoris treatment time is short, the clinical treatment effect is obvious, the adverse reaction is small, safe and reliable.